Global Chagas Disease Drug Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Chagas Disease Drug Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Chagas Disease Drug by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Chagas Disease Drug by Country/Region, 2017, 2022 & 2028

2.2 Chagas Disease Drug Segment by Type

2.2.1 Cz-007

2.2.2 Cz-008

2.2.3 D-121

2.2.4 DNDI-0690

2.2.5 EPLBS-1246

2.2.6 EPLBS-967

2.2.7 Others

2.3 Chagas Disease Drug Sales by Type

2.3.1 Global Chagas Disease Drug Sales Market Share by Type (2017-2022)

2.3.2 Global Chagas Disease Drug Revenue and Market Share by Type (2017-2022)

2.3.3 Global Chagas Disease Drug Sale Price by Type (2017-2022)

2.4 Chagas Disease Drug Segment by Application

2.4.1 Hospital

2.4.2 Clinic

2.4.3 Others

2.5 Chagas Disease Drug Sales by Application

2.5.1 Global Chagas Disease Drug Sale Market Share by Application (2017-2022)

2.5.2 Global Chagas Disease Drug Revenue and Market Share by Application (2017-2022)

2.5.3 Global Chagas Disease Drug Sale Price by Application (2017-2022)

3 Global Chagas Disease Drug by Company

3.1 Global Chagas Disease Drug Breakdown Data by Company

3.1.1 Global Chagas Disease Drug Annual Sales by Company (2020-2022)

3.1.2 Global Chagas Disease Drug Sales Market Share by Company (2020-2022)

3.2 Global Chagas Disease Drug Annual Revenue by Company (2020-2022)

3.2.1 Global Chagas Disease Drug Revenue by Company (2020-2022)

3.2.2 Global Chagas Disease Drug Revenue Market Share by Company (2020-2022)

3.3 Global Chagas Disease Drug Sale Price by Company

3.4 Key Manufacturers Chagas Disease Drug Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Chagas Disease Drug Product Location Distribution

3.4.2 Players Chagas Disease Drug Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Chagas Disease Drug by Geographic Region

4.1 World Historic Chagas Disease Drug Market Size by Geographic Region (2017-2022)

4.1.1 Global Chagas Disease Drug Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Chagas Disease Drug Annual Revenue by Geographic Region

4.2 World Historic Chagas Disease Drug Market Size by Country/Region (2017-2022)

4.2.1 Global Chagas Disease Drug Annual Sales by Country/Region (2017-2022)

4.2.2 Global Chagas Disease Drug Annual Revenue by Country/Region

4.3 Americas Chagas Disease Drug Sales Growth

4.4 APAC Chagas Disease Drug Sales Growth

4.5 Europe Chagas Disease Drug Sales Growth

4.6 Middle East & Africa Chagas Disease Drug Sales Growth

5 Americas

5.1 Americas Chagas Disease Drug Sales by Country

5.1.1 Americas Chagas Disease Drug Sales by Country (2017-2022)

5.1.2 Americas Chagas Disease Drug Revenue by Country (2017-2022)

5.2 Americas Chagas Disease Drug Sales by Type

5.3 Americas Chagas Disease Drug Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Chagas Disease Drug Sales by Region

6.1.1 APAC Chagas Disease Drug Sales by Region (2017-2022)

6.1.2 APAC Chagas Disease Drug Revenue by Region (2017-2022)

6.2 APAC Chagas Disease Drug Sales by Type

6.3 APAC Chagas Disease Drug Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Chagas Disease Drug by Country

7.1.1 Europe Chagas Disease Drug Sales by Country (2017-2022)

7.1.2 Europe Chagas Disease Drug Revenue by Country (2017-2022)

7.2 Europe Chagas Disease Drug Sales by Type

7.3 Europe Chagas Disease Drug Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Chagas Disease Drug by Country

8.1.1 Middle East & Africa Chagas Disease Drug Sales by Country (2017-2022)

8.1.2 Middle East & Africa Chagas Disease Drug Revenue by Country (2017-2022)

8.2 Middle East & Africa Chagas Disease Drug Sales by Type

8.3 Middle East & Africa Chagas Disease Drug Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Chagas Disease Drug

10.3 Manufacturing Process Analysis of Chagas Disease Drug

10.4 Industry Chain Structure of Chagas Disease Drug

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Chagas Disease Drug Distributors

11.3 Chagas Disease Drug Customer

12 World Forecast Review for Chagas Disease Drug by Geographic Region

12.1 Global Chagas Disease Drug Market Size Forecast by Region

12.1.1 Global Chagas Disease Drug Forecast by Region (2023-2028)

12.1.2 Global Chagas Disease Drug Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Chagas Disease Drug Forecast by Type

12.7 Global Chagas Disease Drug Forecast by Application

13 Key Players Analysis

13.1 AstraZeneca Plc

13.1.1 AstraZeneca Plc Company Information

13.1.2 AstraZeneca Plc Chagas Disease Drug Product Offered

13.1.3 AstraZeneca Plc Chagas Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 AstraZeneca Plc Main Business Overview

13.1.5 AstraZeneca Plc Latest Developments

13.2 Bayer AG

13.2.1 Bayer AG Company Information

13.2.2 Bayer AG Chagas Disease Drug Product Offered

13.2.3 Bayer AG Chagas Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Bayer AG Main Business Overview

13.2.5 Bayer AG Latest Developments

13.3 Daiichi Sankyo Co Ltd

13.3.1 Daiichi Sankyo Co Ltd Company Information

13.3.2 Daiichi Sankyo Co Ltd Chagas Disease Drug Product Offered

13.3.3 Daiichi Sankyo Co Ltd Chagas Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Daiichi Sankyo Co Ltd Main Business Overview

13.3.5 Daiichi Sankyo Co Ltd Latest Developments

13.4 Eisai Co Ltd

13.4.1 Eisai Co Ltd Company Information

13.4.2 Eisai Co Ltd Chagas Disease Drug Product Offered

13.4.3 Eisai Co Ltd Chagas Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Eisai Co Ltd Main Business Overview

13.4.5 Eisai Co Ltd Latest Developments

13.5 GlaxoSmithKline Plc

13.5.1 GlaxoSmithKline Plc Company Information

13.5.2 GlaxoSmithKline Plc Chagas Disease Drug Product Offered

13.5.3 GlaxoSmithKline Plc Chagas Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 GlaxoSmithKline Plc Main Business Overview

13.5.5 GlaxoSmithKline Plc Latest Developments

13.6 Grupo Praxis Pharmaceutical SA

13.6.1 Grupo Praxis Pharmaceutical SA Company Information

13.6.2 Grupo Praxis Pharmaceutical SA Chagas Disease Drug Product Offered

13.6.3 Grupo Praxis Pharmaceutical SA Chagas Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Grupo Praxis Pharmaceutical SA Main Business Overview

13.6.5 Grupo Praxis Pharmaceutical SA Latest Developments

13.7 Humanigen Inc

13.7.1 Humanigen Inc Company Information

13.7.2 Humanigen Inc Chagas Disease Drug Product Offered

13.7.3 Humanigen Inc Chagas Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Humanigen Inc Main Business Overview

13.7.5 Humanigen Inc Latest Developments

13.8 Kancera AB

13.8.1 Kancera AB Company Information

13.8.2 Kancera AB Chagas Disease Drug Product Offered

13.8.3 Kancera AB Chagas Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Kancera AB Main Business Overview

13.8.5 Kancera AB Latest Developments

13.9 Merck & Co Inc

13.9.1 Merck & Co Inc Company Information

13.9.2 Merck & Co Inc Chagas Disease Drug Product Offered

13.9.3 Merck & Co Inc Chagas Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Merck & Co Inc Main Business Overview

13.9.5 Merck & Co Inc Latest Developments

13.10 Novartis AG

13.10.1 Novartis AG Company Information

13.10.2 Novartis AG Chagas Disease Drug Product Offered

13.10.3 Novartis AG Chagas Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Novartis AG Main Business Overview

13.10.5 Novartis AG Latest Developments

13.11 Oblita Therapeutics BVBA

13.11.1 Oblita Therapeutics BVBA Company Information

13.11.2 Oblita Therapeutics BVBA Chagas Disease Drug Product Offered

13.11.3 Oblita Therapeutics BVBA Chagas Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Oblita Therapeutics BVBA Main Business Overview

13.11.5 Oblita Therapeutics BVBA Latest Developments

13.12 Sanofi

13.12.1 Sanofi Company Information

13.12.2 Sanofi Chagas Disease Drug Product Offered

13.12.3 Sanofi Chagas Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Sanofi Main Business Overview

13.12.5 Sanofi Latest Developments

14 Research Findings and Conclusion

Table 1. Chagas Disease Drug Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Chagas Disease Drug Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Cz-007

Table 4. Major Players of Cz-008

Table 5. Major Players of D-121

Table 6. Major Players of DNDI-0690

Table 7. Major Players of EPLBS-1246

Table 8. Major Players of EPLBS-967

Table 9. Major Players of Others

Table 10. Global Chagas Disease Drug Sales by Type (2017-2022) & (K Pcs)

Table 11. Global Chagas Disease Drug Sales Market Share by Type (2017-2022)

Table 12. Global Chagas Disease Drug Revenue by Type (2017-2022) & ($ million)

Table 13. Global Chagas Disease Drug Revenue Market Share by Type (2017-2022)

Table 14. Global Chagas Disease Drug Sale Price by Type (2017-2022) & (USD/Pcs)

Table 15. Global Chagas Disease Drug Sales by Application (2017-2022) & (K Pcs)

Table 16. Global Chagas Disease Drug Sales Market Share by Application (2017-2022)

Table 17. Global Chagas Disease Drug Revenue by Application (2017-2022)

Table 18. Global Chagas Disease Drug Revenue Market Share by Application (2017-2022)

Table 19. Global Chagas Disease Drug Sale Price by Application (2017-2022) & (USD/Pcs)

Table 20. Global Chagas Disease Drug Sales by Company (2020-2022) & (K Pcs)

Table 21. Global Chagas Disease Drug Sales Market Share by Company (2020-2022)

Table 22. Global Chagas Disease Drug Revenue by Company (2020-2022) ($ Millions)

Table 23. Global Chagas Disease Drug Revenue Market Share by Company (2020-2022)

Table 24. Global Chagas Disease Drug Sale Price by Company (2020-2022) & (USD/Pcs)

Table 25. Key Manufacturers Chagas Disease Drug Producing Area Distribution and Sales Area

Table 26. Players Chagas Disease Drug Products Offered

Table 27. Chagas Disease Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 28. New Products and Potential Entrants

Table 29. Mergers & Acquisitions, Expansion

Table 30. Global Chagas Disease Drug Sales by Geographic Region (2017-2022) & (K Pcs)

Table 31. Global Chagas Disease Drug Sales Market Share Geographic Region (2017-2022)

Table 32. Global Chagas Disease Drug Revenue by Geographic Region (2017-2022) & ($ millions)

Table 33. Global Chagas Disease Drug Revenue Market Share by Geographic Region (2017-2022)

Table 34. Global Chagas Disease Drug Sales by Country/Region (2017-2022) & (K Pcs)

Table 35. Global Chagas Disease Drug Sales Market Share by Country/Region (2017-2022)

Table 36. Global Chagas Disease Drug Revenue by Country/Region (2017-2022) & ($ millions)

Table 37. Global Chagas Disease Drug Revenue Market Share by Country/Region (2017-2022)

Table 38. Americas Chagas Disease Drug Sales by Country (2017-2022) & (K Pcs)

Table 39. Americas Chagas Disease Drug Sales Market Share by Country (2017-2022)

Table 40. Americas Chagas Disease Drug Revenue by Country (2017-2022) & ($ Millions)

Table 41. Americas Chagas Disease Drug Revenue Market Share by Country (2017-2022)

Table 42. Americas Chagas Disease Drug Sales by Type (2017-2022) & (K Pcs)

Table 43. Americas Chagas Disease Drug Sales Market Share by Type (2017-2022)

Table 44. Americas Chagas Disease Drug Sales by Application (2017-2022) & (K Pcs)

Table 45. Americas Chagas Disease Drug Sales Market Share by Application (2017-2022)

Table 46. APAC Chagas Disease Drug Sales by Region (2017-2022) & (K Pcs)

Table 47. APAC Chagas Disease Drug Sales Market Share by Region (2017-2022)

Table 48. APAC Chagas Disease Drug Revenue by Region (2017-2022) & ($ Millions)

Table 49. APAC Chagas Disease Drug Revenue Market Share by Region (2017-2022)

Table 50. APAC Chagas Disease Drug Sales by Type (2017-2022) & (K Pcs)

Table 51. APAC Chagas Disease Drug Sales Market Share by Type (2017-2022)

Table 52. APAC Chagas Disease Drug Sales by Application (2017-2022) & (K Pcs)

Table 53. APAC Chagas Disease Drug Sales Market Share by Application (2017-2022)

Table 54. Europe Chagas Disease Drug Sales by Country (2017-2022) & (K Pcs)

Table 55. Europe Chagas Disease Drug Sales Market Share by Country (2017-2022)

Table 56. Europe Chagas Disease Drug Revenue by Country (2017-2022) & ($ Millions)

Table 57. Europe Chagas Disease Drug Revenue Market Share by Country (2017-2022)

Table 58. Europe Chagas Disease Drug Sales by Type (2017-2022) & (K Pcs)

Table 59. Europe Chagas Disease Drug Sales Market Share by Type (2017-2022)

Table 60. Europe Chagas Disease Drug Sales by Application (2017-2022) & (K Pcs)

Table 61. Europe Chagas Disease Drug Sales Market Share by Application (2017-2022)

Table 62. Middle East & Africa Chagas Disease Drug Sales by Country (2017-2022) & (K Pcs)

Table 63. Middle East & Africa Chagas Disease Drug Sales Market Share by Country (2017-2022)

Table 64. Middle East & Africa Chagas Disease Drug Revenue by Country (2017-2022) & ($ Millions)

Table 65. Middle East & Africa Chagas Disease Drug Revenue Market Share by Country (2017-2022)

Table 66. Middle East & Africa Chagas Disease Drug Sales by Type (2017-2022) & (K Pcs)

Table 67. Middle East & Africa Chagas Disease Drug Sales Market Share by Type (2017-2022)

Table 68. Middle East & Africa Chagas Disease Drug Sales by Application (2017-2022) & (K Pcs)

Table 69. Middle East & Africa Chagas Disease Drug Sales Market Share by Application (2017-2022)

Table 70. Key Market Drivers & Growth Opportunities of Chagas Disease Drug

Table 71. Key Market Challenges & Risks of Chagas Disease Drug

Table 72. Key Industry Trends of Chagas Disease Drug

Table 73. Chagas Disease Drug Raw Material

Table 74. Key Suppliers of Raw Materials

Table 75. Chagas Disease Drug Distributors List

Table 76. Chagas Disease Drug Customer List

Table 77. Global Chagas Disease Drug Sales Forecast by Region (2023-2028) & (K Pcs)

Table 78. Global Chagas Disease Drug Sales Market Forecast by Region

Table 79. Global Chagas Disease Drug Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Global Chagas Disease Drug Revenue Market Share Forecast by Region (2023-2028)

Table 81. Americas Chagas Disease Drug Sales Forecast by Country (2023-2028) & (K Pcs)

Table 82. Americas Chagas Disease Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 83. APAC Chagas Disease Drug Sales Forecast by Region (2023-2028) & (K Pcs)

Table 84. APAC Chagas Disease Drug Revenue Forecast by Region (2023-2028) & ($ millions)

Table 85. Europe Chagas Disease Drug Sales Forecast by Country (2023-2028) & (K Pcs)

Table 86. Europe Chagas Disease Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 87. Middle East & Africa Chagas Disease Drug Sales Forecast by Country (2023-2028) & (K Pcs)

Table 88. Middle East & Africa Chagas Disease Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 89. Global Chagas Disease Drug Sales Forecast by Type (2023-2028) & (K Pcs)

Table 90. Global Chagas Disease Drug Sales Market Share Forecast by Type (2023-2028)

Table 91. Global Chagas Disease Drug Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 92. Global Chagas Disease Drug Revenue Market Share Forecast by Type (2023-2028)

Table 93. Global Chagas Disease Drug Sales Forecast by Application (2023-2028) & (K Pcs)

Table 94. Global Chagas Disease Drug Sales Market Share Forecast by Application (2023-2028)

Table 95. Global Chagas Disease Drug Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 96. Global Chagas Disease Drug Revenue Market Share Forecast by Application (2023-2028)

Table 97. AstraZeneca Plc Basic Information, Chagas Disease Drug Manufacturing Base, Sales Area and Its Competitors

Table 98. AstraZeneca Plc Chagas Disease Drug Product Offered

Table 99. AstraZeneca Plc Chagas Disease Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 100. AstraZeneca Plc Main Business

Table 101. AstraZeneca Plc Latest Developments

Table 102. Bayer AG Basic Information, Chagas Disease Drug Manufacturing Base, Sales Area and Its Competitors

Table 103. Bayer AG Chagas Disease Drug Product Offered

Table 104. Bayer AG Chagas Disease Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 105. Bayer AG Main Business

Table 106. Bayer AG Latest Developments

Table 107. Daiichi Sankyo Co Ltd Basic Information, Chagas Disease Drug Manufacturing Base, Sales Area and Its Competitors

Table 108. Daiichi Sankyo Co Ltd Chagas Disease Drug Product Offered

Table 109. Daiichi Sankyo Co Ltd Chagas Disease Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 110. Daiichi Sankyo Co Ltd Main Business

Table 111. Daiichi Sankyo Co Ltd Latest Developments

Table 112. Eisai Co Ltd Basic Information, Chagas Disease Drug Manufacturing Base, Sales Area and Its Competitors

Table 113. Eisai Co Ltd Chagas Disease Drug Product Offered

Table 114. Eisai Co Ltd Chagas Disease Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 115. Eisai Co Ltd Main Business

Table 116. Eisai Co Ltd Latest Developments

Table 117. GlaxoSmithKline Plc Basic Information, Chagas Disease Drug Manufacturing Base, Sales Area and Its Competitors

Table 118. GlaxoSmithKline Plc Chagas Disease Drug Product Offered

Table 119. GlaxoSmithKline Plc Chagas Disease Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 120. GlaxoSmithKline Plc Main Business

Table 121. GlaxoSmithKline Plc Latest Developments

Table 122. Grupo Praxis Pharmaceutical SA Basic Information, Chagas Disease Drug Manufacturing Base, Sales Area and Its Competitors

Table 123. Grupo Praxis Pharmaceutical SA Chagas Disease Drug Product Offered

Table 124. Grupo Praxis Pharmaceutical SA Chagas Disease Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 125. Grupo Praxis Pharmaceutical SA Main Business

Table 126. Grupo Praxis Pharmaceutical SA Latest Developments

Table 127. Humanigen Inc Basic Information, Chagas Disease Drug Manufacturing Base, Sales Area and Its Competitors

Table 128. Humanigen Inc Chagas Disease Drug Product Offered

Table 129. Humanigen Inc Chagas Disease Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 130. Humanigen Inc Main Business

Table 131. Humanigen Inc Latest Developments

Table 132. Kancera AB Basic Information, Chagas Disease Drug Manufacturing Base, Sales Area and Its Competitors

Table 133. Kancera AB Chagas Disease Drug Product Offered

Table 134. Kancera AB Chagas Disease Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 135. Kancera AB Main Business

Table 136. Kancera AB Latest Developments

Table 137. Merck & Co Inc Basic Information, Chagas Disease Drug Manufacturing Base, Sales Area and Its Competitors

Table 138. Merck & Co Inc Chagas Disease Drug Product Offered

Table 139. Merck & Co Inc Chagas Disease Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 140. Merck & Co Inc Main Business

Table 141. Merck & Co Inc Latest Developments

Table 142. Novartis AG Basic Information, Chagas Disease Drug Manufacturing Base, Sales Area and Its Competitors

Table 143. Novartis AG Chagas Disease Drug Product Offered

Table 144. Novartis AG Chagas Disease Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 145. Novartis AG Main Business

Table 146. Novartis AG Latest Developments

Table 147. Oblita Therapeutics BVBA Basic Information, Chagas Disease Drug Manufacturing Base, Sales Area and Its Competitors

Table 148. Oblita Therapeutics BVBA Chagas Disease Drug Product Offered

Table 149. Oblita Therapeutics BVBA Chagas Disease Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 150. Oblita Therapeutics BVBA Main Business

Table 151. Oblita Therapeutics BVBA Latest Developments

Table 152. Sanofi Basic Information, Chagas Disease Drug Manufacturing Base, Sales Area and Its Competitors

Table 153. Sanofi Chagas Disease Drug Product Offered

Table 154. Sanofi Chagas Disease Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 155. Sanofi Main Business

Table 156. Sanofi Latest Developments

List of Figures

Figure 1. Picture of Chagas Disease Drug

Figure 2. Chagas Disease Drug Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Chagas Disease Drug Sales Growth Rate 2017-2028 (K Pcs)

Figure 7. Global Chagas Disease Drug Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Chagas Disease Drug Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Cz-007

Figure 10. Product Picture of Cz-008

Figure 11. Product Picture of D-121

Figure 12. Product Picture of DNDI-0690

Figure 13. Product Picture of EPLBS-1246

Figure 14. Product Picture of EPLBS-967

Figure 15. Product Picture of Others

Figure 16. Global Chagas Disease Drug Sales Market Share by Type in 2021

Figure 17. Global Chagas Disease Drug Revenue Market Share by Type (2017-2022)

Figure 18. Chagas Disease Drug Consumed in Hospital

Figure 19. Global Chagas Disease Drug Market: Hospital (2017-2022) & (K Pcs)

Figure 20. Chagas Disease Drug Consumed in Clinic

Figure 21. Global Chagas Disease Drug Market: Clinic (2017-2022) & (K Pcs)

Figure 22. Chagas Disease Drug Consumed in Others

Figure 23. Global Chagas Disease Drug Market: Others (2017-2022) & (K Pcs)

Figure 24. Global Chagas Disease Drug Sales Market Share by Application (2017-2022)

Figure 25. Global Chagas Disease Drug Revenue Market Share by Application in 2021

Figure 26. Chagas Disease Drug Revenue Market by Company in 2021 ($ Million)

Figure 27. Global Chagas Disease Drug Revenue Market Share by Company in 2021

Figure 28. Global Chagas Disease Drug Sales Market Share by Geographic Region (2017-2022)

Figure 29. Global Chagas Disease Drug Revenue Market Share by Geographic Region in 2021

Figure 30. Global Chagas Disease Drug Sales Market Share by Region (2017-2022)

Figure 31. Global Chagas Disease Drug Revenue Market Share by Country/Region in 2021

Figure 32. Americas Chagas Disease Drug Sales 2017-2022 (K Pcs)

Figure 33. Americas Chagas Disease Drug Revenue 2017-2022 ($ Millions)

Figure 34. APAC Chagas Disease Drug Sales 2017-2022 (K Pcs)

Figure 35. APAC Chagas Disease Drug Revenue 2017-2022 ($ Millions)

Figure 36. Europe Chagas Disease Drug Sales 2017-2022 (K Pcs)

Figure 37. Europe Chagas Disease Drug Revenue 2017-2022 ($ Millions)

Figure 38. Middle East & Africa Chagas Disease Drug Sales 2017-2022 (K Pcs)

Figure 39. Middle East & Africa Chagas Disease Drug Revenue 2017-2022 ($ Millions)

Figure 40. Americas Chagas Disease Drug Sales Market Share by Country in 2021

Figure 41. Americas Chagas Disease Drug Revenue Market Share by Country in 2021

Figure 42. United States Chagas Disease Drug Revenue Growth 2017-2022 ($ Millions)

Figure 43. Canada Chagas Disease Drug Revenue Growth 2017-2022 ($ Millions)

Figure 44. Mexico Chagas Disease Drug Revenue Growth 2017-2022 ($ Millions)

Figure 45. Brazil Chagas Disease Drug Revenue Growth 2017-2022 ($ Millions)

Figure 46. APAC Chagas Disease Drug Sales Market Share by Region in 2021

Figure 47. APAC Chagas Disease Drug Revenue Market Share by Regions in 2021

Figure 48. China Chagas Disease Drug Revenue Growth 2017-2022 ($ Millions)

Figure 49. Japan Chagas Disease Drug Revenue Growth 2017-2022 ($ Millions)

Figure 50. South Korea Chagas Disease Drug Revenue Growth 2017-2022 ($ Millions)

Figure 51. Southeast Asia Chagas Disease Drug Revenue Growth 2017-2022 ($ Millions)

Figure 52. India Chagas Disease Drug Revenue Growth 2017-2022 ($ Millions)

Figure 53. Australia Chagas Disease Drug Revenue Growth 2017-2022 ($ Millions)

Figure 54. Europe Chagas Disease Drug Sales Market Share by Country in 2021

Figure 55. Europe Chagas Disease Drug Revenue Market Share by Country in 2021

Figure 56. Germany Chagas Disease Drug Revenue Growth 2017-2022 ($ Millions)

Figure 57. France Chagas Disease Drug Revenue Growth 2017-2022 ($ Millions)

Figure 58. UK Chagas Disease Drug Revenue Growth 2017-2022 ($ Millions)

Figure 59. Italy Chagas Disease Drug Revenue Growth 2017-2022 ($ Millions)

Figure 60. Russia Chagas Disease Drug Revenue Growth 2017-2022 ($ Millions)

Figure 61. Middle East & Africa Chagas Disease Drug Sales Market Share by Country in 2021

Figure 62. Middle East & Africa Chagas Disease Drug Revenue Market Share by Country in 2021

Figure 63. Egypt Chagas Disease Drug Revenue Growth 2017-2022 ($ Millions)

Figure 64. South Africa Chagas Disease Drug Revenue Growth 2017-2022 ($ Millions)

Figure 65. Israel Chagas Disease Drug Revenue Growth 2017-2022 ($ Millions)

Figure 66. Turkey Chagas Disease Drug Revenue Growth 2017-2022 ($ Millions)

Figure 67. GCC Country Chagas Disease Drug Revenue Growth 2017-2022 ($ Millions)

Figure 68. Manufacturing Cost Structure Analysis of Chagas Disease Drug in 2021

Figure 69. Manufacturing Process Analysis of Chagas Disease Drug

Figure 70. Industry Chain Structure of Chagas Disease Drug

Figure 71. Channels of Distribution

Figure 72. Distributors Profiles